Abstract
Massively parallel sequencing of cell free fetal DNA (cffDNA) obtained from maternal plasma is used to detect fetal trisomies and selected sex chromosomal aneuploidies. Different technologies can be used to detect fetal chromosomopathies noninvasively, such as Next Generation sequencing and microarrays. In this case report, we show a procedure for detecting chromosomal imbalances as a result of balanced translocations inherited from parents, using noninvasive prenatal detection of common aneuploidies based protocol. This case study illustrates the potential power of whole-genome semiconductor sequencing when used to augment the diagnostic spectrum of noninvasive prenatal testing to detection of copy number variants.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
